scholarly article | Q13442814 |
P50 | author | Alan R. Zinsmeister | Q64368056 |
Darren Burton | Q125486958 | ||
P2093 | author name string | M Camilleri | |
A E Bharucha | |||
A Shin | |||
J Iturrino | |||
I-D Jeong | |||
P2860 | cites work | Statistical methods for assessing agreement between two methods of clinical measurement | Q26778461 |
Clinical Features of Idiopathic Gastroparesis Vary With Sex, Body Mass, Symptom Onset, Delay in Gastric Emptying, and Gastroparesis Severity | Q34946438 | ||
Effect of a somatostatin analogue on gastric motor and sensory functions in healthy humans | Q35596092 | ||
Gastric motor and sensory functions in obesity | Q36099904 | ||
High body mass alters colonic sensory-motor function and transit in humans | Q36846509 | ||
Consensus recommendations for gastric emptying scintigraphy: a joint report of the American Neurogastroenterology and Motility Society and the Society of Nuclear Medicine | Q37009041 | ||
Towards a less costly but accurate test of gastric emptying and small bowel transit | Q41152382 | ||
A longitudinal study of gastric emptying and upper gastrointestinal symptoms in patients with diabetes mellitus | Q44213246 | ||
Human gastric emptying and colonic filling of solids characterized by a new method | Q44578488 | ||
Gastric sensorimotor functions and hormone profile in normal weight, overweight, and obese people | Q47314674 | ||
Independent influences of body mass and gastric volumes on satiation in humans. | Q51531887 | ||
Is there a role for gastric accommodation and satiety in asymptomatic obese people? | Q51546185 | ||
Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction. | Q51622063 | ||
Effect of female sex hormone supplementation and withdrawal on gastrointestinal and colonic transit in postmenopausal women. | Q51787140 | ||
Assessment of functional gastrointestinal disease: the bowel disease questionnaire | Q68591715 | ||
Evaluation of an inexpensive screening scintigraphic test of gastric emptying | Q72354305 | ||
[13C]octanoic acid breath test for gastric emptying of solids: accuracy, reproducibility, and comparison with scintigraphy | Q73212073 | ||
Assessment of gastric emptying using a low fat meal: establishment of international control values | Q73999675 | ||
Reproducibility and simplification of 13C-octanoic acid breath test for gastric emptying of solids | Q74111809 | ||
Performance characteristics of scintigraphic transit measurements for studies of experimental therapies | Q77067415 | ||
P433 | issue | 12 | |
P304 | page(s) | 1076-e562 | |
P577 | publication date | 2012-07-02 | |
P1433 | published in | Neurogastroenterology and Motility | Q15767493 |
P1476 | title | Performance characteristics of scintigraphic measurement of gastric emptying of solids in healthy participants | |
P478 | volume | 24 |
Q38133838 | A ghrelin agonist fails to show benefit in patients with diabetic gastroparesis: let's not throw the baby out with the bath water. |
Q64992956 | Allelic variant in the glucagon-like peptide 1 receptor gene associated with greater effect of liraglutide and exenatide on gastric emptying: A pilot pharmacogenetics study. |
Q94948726 | Association between gastrointestinal phenotypes and weight gain in younger adults: a prospective 4-year cohort study |
Q36494385 | Association of HLA-DQ gene with bowel transit, barrier function, and inflammation in irritable bowel syndrome with diarrhea |
Q48315518 | Clinical assessment of gastric emptying and sensory function utilizing gamma scintigraphy: Establishment of reference intervals for the liquid and solid components of the Nottingham test meal in healthy subjects |
Q47561661 | Clinical utility of gastric emptying scintigraphy: Patient and physician perspectives. |
Q38079140 | Current management strategies and emerging treatments for functional dyspepsia |
Q34037574 | Diagnostic assessment of diabetic gastroparesis |
Q34857399 | Disturbances of gastrointestinal transit and autonomic functions in postural orthostatic tachycardia syndrome |
Q38778630 | Drug-resin drug interactions in patients with delayed gastric emptying: What is optimal time window for drug administration? |
Q35893549 | Effect of Amitriptyline and Escitalopram on Functional Dyspepsia: A Multicenter, Randomized Controlled Study |
Q36319562 | Effect of neostigmine on gastroduodenal motility in patients with suspected gastrointestinal motility disorders |
Q47283483 | Effects of Antidepressants on Gastric Function in Patients with Functional Dyspepsia |
Q47944822 | Effects of NK1 receptors on gastric motor functions and satiation in healthy humans: results from a controlled trial with the NK1 antagonist aprepitant |
Q42679290 | Effects of hemin on heme oxygenase-1, gastric emptying, and symptoms in diabetic gastroparesis |
Q47185132 | Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial |
Q94467546 | Epigenetic Alterations Are Associated With Gastric Emptying Disturbances in Diabetes Mellitus |
Q36248001 | Exenatide in obesity with accelerated gastric emptying: a randomized, pharmacodynamics study |
Q52603772 | Expert consensus document: Advances in the diagnosis and classification of gastric and intestinal motility disorders. |
Q57792182 | GI Dysfunctions in Diabetic Gastroenteropathy, their Relationships with Symptoms, and Effects of a GLP-1 antagonist |
Q47775655 | Gastric Motor Dysfunction in Patients With Functional Gastroduodenal Symptoms |
Q36553542 | Gastric antral injections of botulinum toxin delay gastric emptying but do not reduce body weight |
Q51531193 | Gastric emptying of solids in children: reference values for the (13) C-octanoic acid breath test. |
Q35118784 | Gastric emptying scintigraphy results in children are affected by age, anthropometric factors, and study duration |
Q58570237 | Gastroparesis |
Q94446944 | Ileo-colonic delivery of conjugated bile acids improves glucose homeostasis via colonic GLP-1-producing enteroendocrine cells in human obesity and diabetes |
Q36849925 | Interpretation of overall colonic transit in defecation disorders in males and females |
Q37261844 | Measurement of Gastrointestinal and Colonic Motor Functions in Humans and Animals |
Q37691871 | Novel Association of Rectal Evacuation Disorder and Rumination Syndrome: Diagnosis, Co-morbidities and Treatment |
Q38695314 | Novel Diet, Drugs, and Gastric Interventions for Gastroparesis |
Q86837728 | Novel and validated approaches for gastric emptying scintigraphy in patients with suspected gastroparesis |
Q39107442 | Pilot study trialling a new ambulatory method for the clinical assessment of regional gastrointestinal transit using multiple electromagnetic capsules |
Q37624734 | Pilot trial: pregabalin on colonic sensorimotor functions in irritable bowel syndrome |
Q37396985 | Prevalence of colonic motor or evacuation disorders in patients presenting with chronic nausea and vomiting evaluated by a single gastroenterologist in a tertiary referral practice |
Q35118214 | Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy |
Q34298494 | Randomized controlled phase Ib study of ghrelin agonist, RM-131, in type 2 diabetic women with delayed gastric emptying: pharmacokinetics and pharmacodynamics |
Q37564153 | Regional Colonic Transit Pattern Does Not Conclusively Identify Evacuation Disorders in Constipated Patients with Delayed Colonic Transit |
Q38979731 | Regional gastrointestinal transit and pH studied in 215 healthy volunteers using the wireless motility capsule: influence of age, gender, study country and testing protocol. |
Q35804351 | Relationship Between Microbiota of the Colonic Mucosa vs Feces and Symptoms, Colonic Transit, and Methane Production in Female Patients With Chronic Constipation. |
Q47739420 | Relationship of gastric emptying or accommodation with satiation, satiety, and postprandial symptoms in health |
Q38655866 | Reproducibility of assessing fecal microbiota in chronic constipation |
Q88552815 | Reproducibility of gastric emptying assessed with scintigraphy in patients with upper GI symptoms |
Q37248624 | The ghrelin agonist RM-131 accelerates gastric emptying of solids and reduces symptoms in patients with type 1 diabetes mellitus |
Q43749266 | Use of a high caloric liquid meal as an alternative to a solid meal for gastric emptying scintigraphy |
Q90586763 | Validation of Diagnostic and Performance Characteristics of the Wireless Motility Capsule in Patients With Suspected Gastroparesis |
Q38730265 | White Paper AGA: Gastroparesis: Clinical and Regulatory Insights for Clinical Trials |
Search more.